'We need to be part of the solution': lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies.
Saved in:
| Title: | 'We need to be part of the solution': lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies. |
|---|---|
| Authors: | Vogler S; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria., Zimmermann N; Quality Management and Certification Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria., Knoll V; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria., Salcher-Konrad M; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria., Windisch F; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria., Espin J; Andalusian School of Public Health, Granada, Spain., Mantel-Teeuwisse AK; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University, Utrecht, the Netherlands., Panteli D; European Observatory on Health Systems and Policies, Brussels, Belgium., Suleman F; WHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa., Wirtz VJ; WHO Collaborating Center in Pharmaceutical Policy, Department of Global Health, Boston University School of Public Health, Boston, USA., Babar ZU; College of Pharmacy, Qatar University, Doha, Qatar. |
| Source: | Journal of pharmaceutical policy and practice [J Pharm Policy Pract] 2024 Dec 24; Vol. 17 (Suppl 1), pp. 2442002. Date of Electronic Publication: 2024 Dec 24 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa UK Limited Country of Publication: England NLM ID: 101627192 Publication Model: eCollection Cited Medium: Print ISSN: 2052-3211 (Print) Linking ISSN: 20523211 NLM ISO Abbreviation: J Pharm Policy Pract Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39763616 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 'We need to be part of the solution': lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vogler+S%22">Vogler S</searchLink>; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Zimmermann+N%22">Zimmermann N</searchLink>; Quality Management and Certification Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Knoll+V%22">Knoll V</searchLink>; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Salcher-Konrad+M%22">Salcher-Konrad M</searchLink>; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Windisch+F%22">Windisch F</searchLink>; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Espin+J%22">Espin J</searchLink>; Andalusian School of Public Health, Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Mantel-Teeuwisse+AK%22">Mantel-Teeuwisse AK</searchLink>; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Panteli+D%22">Panteli D</searchLink>; European Observatory on Health Systems and Policies, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Suleman+F%22">Suleman F</searchLink>; WHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Wirtz+VJ%22">Wirtz VJ</searchLink>; WHO Collaborating Center in Pharmaceutical Policy, Department of Global Health, Boston University School of Public Health, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Babar+ZU%22">Babar ZU</searchLink>; College of Pharmacy, Qatar University, Doha, Qatar. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101627192%22">Journal of pharmaceutical policy and practice</searchLink> [J Pharm Policy Pract] 2024 Dec 24; Vol. 17 (Suppl 1), pp. 2442002. <i>Date of Electronic Publication: </i>2024 Dec 24 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+UK+Limited%22">Informa UK Limited </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101627192 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2052-3211 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220523211%22">20523211 </searchLink><i>NLM ISO Abbreviation: </i>J Pharm Policy Pract <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39763616 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/20523211.2024.2442002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2442002 Titles: – TitleFull: 'We need to be part of the solution': lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vogler S – PersonEntity: Name: NameFull: Zimmermann N – PersonEntity: Name: NameFull: Knoll V – PersonEntity: Name: NameFull: Salcher-Konrad M – PersonEntity: Name: NameFull: Windisch F – PersonEntity: Name: NameFull: Espin J – PersonEntity: Name: NameFull: Mantel-Teeuwisse AK – PersonEntity: Name: NameFull: Panteli D – PersonEntity: Name: NameFull: Suleman F – PersonEntity: Name: NameFull: Wirtz VJ – PersonEntity: Name: NameFull: Babar ZU IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 12 Text: 2024 Dec 24 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2052-3211 Numbering: – Type: volume Value: 17 – Type: issue Value: Suppl 1 Titles: – TitleFull: Journal of pharmaceutical policy and practice Type: main |
| ResultId | 1 |